Cargando…
Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy
SIMPLE SUMMARY: This study aims to evaluate the induction of immunogenic cell death (ICD) for anticancer immunity by the novel topoisomerase I inhibitor lipotecan. These results show that lipotecan can remarkably elicit ICD and increase tumor immunogenicity, which promotes the therapeutic efficacy o...
Autores principales: | Huang, Kevin Chih-Yang, Chiang, Shu-Fen, Yang, Pei-Chen, Ke, Tao-Wei, Chen, Tsung-Wei, Hu, Ching-Han, Huang, Yi-Wen, Chang, Hsin-Yu, Chen, William Tzu-Liang, Chao, K. S. Clifford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998596/ https://www.ncbi.nlm.nih.gov/pubmed/33799527 http://dx.doi.org/10.3390/cancers13061218 |
Ejemplares similares
-
Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade
por: Huang, Kevin Chih-Yang, et al.
Publicado: (2022) -
TLC388 Induces DNA Damage and G2 Phase Cell Cycle Arrest in Human Non-Small Cell Lung Cancer Cells
por: Wu, Kun-Ming, et al.
Publicado: (2020) -
Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy
por: Huang, Kevin Chih-Yang, et al.
Publicado: (2020) -
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer
por: Huang, Chih-Yang, et al.
Publicado: (2018) -
Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
por: Huang, Kevin Chih-Yang, et al.
Publicado: (2020)